|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: MICROCIDE PHARMACEUTICALS INC, 10-Q, 2000-11-14 |
Next: CRESCENT REAL ESTATE EQUITIES LTD PARTNERSHIP, 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<CIK> 0001010915
<NAME> MICROCIDE PHARMACEUTICALS, INC.
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JUL-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 2,785
<SECURITIES> 12,439
<RECEIVABLES> 612
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 16,308
<PP&E> 20,391
<DEPRECIATION> (14,152)
<TOTAL-ASSETS> 23,404
<CURRENT-LIABILITIES> 3,910
<BONDS> 0
0
0
<COMMON> 68,296
<OTHER-SE> (49,788)
<TOTAL-LIABILITY-AND-EQUITY> 23,404
<SALES> 0
<TOTAL-REVENUES> 1,454
<CGS> 0
<TOTAL-COSTS> 5,227
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 59
<INCOME-PRETAX> (3,563)
<INCOME-TAX> 0
<INCOME-CONTINUING> (3,563)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (3,563)
<EPS-BASIC> (0.31)
<EPS-DILUTED> (0.31)
</TABLE>
|
|